ACIP Hepatitis A Immunization Recommendations: Vaccine and Immune Globulin Guidelines

Recommendations from the Advisory Committee on Immunization Practices (ACIP) for using two newly licensed hepatitis A vaccines, HAVRIX and VAQTA, in persons aged 2 years and older. The report updates previous guidelines for immune globulin (IG) use for protection against hepatitis A, superseding the 1990 MMWR publication. It details circumstances where hepatitis A vaccine can replace IG for preexposure protection and maintains existing IG recommendations for postexposure prophylaxis.

Use Cases

• Analyzing updates to public health immunization protocols based on the introduction of new vaccines.
• Comparing preexposure and postexposure prophylaxis recommendations for hepatitis A.
• Studying the evolution of clinical guidelines by comparing these 1990s recommendations to later versions.

Strengths

• Provides specific recommendations for two named vaccines, HAVRIX and VAQTA.
• Explicitly updates a prior publication (MMWR 1990;39[No. RR-2]:1-5), establishing a clear lineage.
• Specifies a target population of persons aged 2 years and older.

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• Last update date is unknown; freshness unverified.

Provenance

Source

Advisory Committee on Immunization Practices (ACIP)

Collection Method

Likely contains formal clinical recommendations and guideline text.